Aigen Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Aigen Investment Management's PFE Position: Q1 2026 in Review
Aigen Investment Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 83,314 shares — an estimated $2.07M sold.
Aigen Investment Management first reported a position in PFE in Q1 2020 and held it in 12 quarters. The position peaked at $14.6M in Q1 2023. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Aigen Investment Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Aigen Investment Management sold 83,314 Pfizer shares in Q1 2026, an estimated $2.07M.
- Aigen Investment Management first reported a position in Pfizer in Q1 2020 and held it in 12 quarters.
- Aigen Investment Management's Pfizer position peaked at $14.6M in Q1 2023.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.